|
CN104865389A
|
|
Method and kit for detecting human serum hybrid light chain antibody
|
|
CN104808006A
|
|
Glycosylated hemoglobin reference material and preparation method thereof
|
|
CN104569397A
|
|
Quality control sample for detecting breast cancer and preparation method of quality control sample
|
|
CN104293969A
|
|
Reagent for predicting ankylosing spondylitis susceptibility
|
|
CN104313140A
|
|
Reagent and method for predicting susceptibility to ankylosing spondylitis
|
|
CN104313144A
|
|
Reagent for detecting susceptibility of Alzheimer's disease
|
|
CN104313141A
|
|
Detecting reagent predicting susceptivity of ankylosing spondylitis
|
|
CN104293958A
|
|
Kit and method for predicting ankylosing spondylitis susceptibility
|
|
CN104293959A
|
|
Kit for predicating susceptibility to ankylosing spondylitis
|
|
CN104120194A
|
|
Method for designing virus RNA (Ribonucleic Acid) detection primer and kit
|
|
CN103882110A
|
|
Reagent of detecting susceptibility of ankylosing spondylitis
|
|
CN103882113A
|
|
Kit for predicting susceptibility of ankylosing spondylitis
|
|
CN103710445A
|
|
Kit for predicting ankylosing spondylitis susceptibility
|
|
CN103710448A
|
|
Method and kit for predicting susceptibility of ankylosing spondylitis
|
|
CN103882112A
|
|
Reagent and method for predicting ankylosing spondylitis susceptibility
|
|
CN103725781A
|
|
Kit and method for predicting susceptibility of ankylosing spondylitis
|
|
CN103710446A
|
|
Reagent and method for predicting ankylosing spondylitis susceptibility
|
|
CN103710447A
|
|
Method and reagent for predicting susceptibility of ankylosing spondylitis
|
|
CN103882111A
|
|
Reagent for predicting susceptibility of ankylosing spondylitis
|
|
CN103695549A
|
|
Agent for predicting susceptibility to ankylosing spondylitis
|
